COMPASS THERAPEUTICS, INC. Debt Securities, Available-for-sale, Amortized Cost
COMPASS THERAPEUTICS, INC. (CMPX) had Debt Securities, Available-for-sale, Amortized Cost of $144.68 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $144.68M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $139.68M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $177.98M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $173.41M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-06-30 | $144.68M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $139.68M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $177.98M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $173.41M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $77.89M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $71.40M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $83.03M 10-K · filed 2026-03-05 |
| 2024-09-30 | $98.11M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $126.91M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $132.67M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $128.20M 10-K · filed 2025-02-27 |
| 2023-09-30 | $133.71M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $149.98M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $148.29M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $151.97M 10-K · filed 2024-03-21 |
| 2022-09-30 | $104.76M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $106.29M 10-Q · filed 2022-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |